Please login to the form below
Mimpara
This page shows the latest Mimpara news and features for those working in and with pharma, biotech and healthcare.
NICE set to back Parsabiv for kidney disease complication
be treated with Amgen's older drug Sensipar/Mimpara (cinacalcet) - and provided Amgen supplies the drug at an agreed discount.
Latest news
-
Amgen's chronic kidney disease drug Parsabiv cleared in US
Parsabiv (etelcalcetide) - a follow-up to Amgen's blockbuster Sensipar/Mimpara (cinacalcet) - has been given a green light to treat adult CKD patients on dialysis who develop secondary hyperparathyroidism (sHPT).
-
Amgen wins European approval for Parsabiv
Sensipar/Mimpara blockbuster.
-
FDA knocks back Amgen's chronic kidney disease treatment
up to blockbuster Sensipar/Mimpara.
-
CHMP recommends 19 new medicines for European approval
of Amgen's hyperparathyroidism and parathyroid carcinoma drug Mimpara.
-
Amgen's Sensipar follow-up clears phase III trial
AMG 416 meets objectives in hyperparathyroidism. One of the unsung heroes in Amgen's product portfolio is Sensipar/Mimpara for secondary hyperparathyroidism (HPT), which has grown fairly steadily since its launch
More from news
Approximately 1 fully matching, plus 11 partially matching documents found.
Latest from PMHub
-
PAN and DJM win prestigious Global Award
Creative agency PAN and sister digital agency DJM Solutions have won a prestigious Global Award for their animation of Mimpara Man’ for Amgen. ... Creative agency PAN and sister digital agency DJM Solutions have won a prestigious Global Award for their
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Healthcare Lead Copywriter
-
Competitive
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
Healthcare Account Director
-
Competitive
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
-
Medical Editor
-
Competitive
-
Healthcare Senior Account Manager
-
Competitive
- New study identifies drugs that are safe to use in COVID-19 treatment
- Celltrion’s investigational mAb cuts COVID-19 recovery time
- J&J trims the size of its phase 3 COVID-19 vaccine trial
- Experimental Chinese COVID-19 vaccine is safe, according to researchers
- AZ’s COVID-19 vaccine trial to continue after Brazilian volunteer death
- COVID-19 vaccine developers respond to new strain
- Live Webinar: COVID-19 Has Changed Live Events Forever!
- New hire and promotions announced at Evoke KYNE
- Amgen strikes $240m autoimmune deal with Evoq Therapeutics
- Lucid Group bolster its talent with a further twelve new starters for 2021
- UK pharmacies to begin administering COVID-19 vaccinations
- PHE study finds people who have had COVID-19 can still transmit the virus
PMHub
Viseven
Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...
Latest intelligence
- AstraZeneca’s focus on diagnosing and managing chronic kidney disease
- People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
- Delphi Technique Virtual Co-creation: A Customer Story
- How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
- Three ways AI will change healthcare in the next decade
- Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...
Quick links
Infographics
